Click on headlines below to download research
Executive interview
Executive interview - Mybucks at EKF 2019 | 06/12/2019
In this interview, Timothy Nuy, CEO of MyBucks, discusses the company’s progress on the recapitalisation measures announced in March, the business…
Executive interview
Executive interview - PAION at EKF 2019 | 06/12/2019
In this interview, Dr James Phillips, CEO of Paion, provides an overview of the company and its focus on anaesthesia products. He explains what differentiates…
Executive interview
Executive interview - Lloyd Fonds at EKF 2019 | 06/12/2019
In this interview, Klaus M Pinter, CEO at Lloyds Fonds, discusses the company’s new strategy and business model. He explains why he is confident…
Executive interview
Executive interview - Ringmetall at EKF 2019 | 06/12/2019
In this interview, Christoph Petri, CEO of Ringmetall, provides an overview of the business. He discusses the company’s key technologies and strengths,…
Executive interview
Executive interview - PANTAFLIX at EKF 2019 | 06/12/2019
In this interview, Nicolas Paalzow, CEO at PANTAFLIX discussed the company’s new corporate strategy. He covered how the SVoD and AVoD channels will…
Executive interview
Executive interview - CLIQ Digital at EKF 2019 | 06/12/2019
In this interview, Ben Bos, a member of the board at CLIQ Digital, discusses the company’s Q319 figures, how the business intends to drive gross…
Executive interview
Executive interview - EQS at EKF 2019 | 06/12/2019
In this interview, Achim Weick, CEO of EQS Group, discusses the markets it operates in how regulation helps to drive the growth profile and how its cloud-based…
Drought affects profits
Tonkens Agrar | 06/12/2019
Tonkens continued with its strategy of increasing volumes of higher-margin processed vegetables in FY18/19, supporting a 17% y-o-y increase in group revenue.…
Seeking sustainable growth
paragon | 27/11/2019
While Q319 results confirm the anticipated issues in Electromobility (Voltabox), with a more robust performance from the automotive segments (Electronics…
Exciting viewing ahead
Borussia Dortmund | 15/11/2019
Borussia Dortmund’s Q120 results exhibited typical volatility due to the key summer transfer window. Excluding the volatile transfer revenue, there…
Focused on delivery
Cyan | 14/11/2019
Over the last 12 months Cyan has focused on integrating its I-New acquisition and preparing for its Orange roll-out. Sustaining this focus on delivery…
Q319 results highlight successful year to date
Medigene | 14/11/2019
Enrolment of patients in Medigene’s MDG1011 Phase I/II trial continues, albeit at a slower rate than initially expected, with initial data from the…
Making efforts towards Naga Group 2.0
The NAGA Group | 11/11/2019
NAGA Group has largely completed its restructuring (initiated in April 2019) aimed at cost savings and increased focus on its only profitable product,…
The land of opportunity awaits NanoTherm
MagForce | 11/11/2019
MagForce is making progress in its strategy to drive the uptake of its thermal ablation treatment, NanoTherm. It is approved in Europe for brain tumours…
Fibreless optical links in the skies
Mynaric | 11/11/2019
Mynaric has developed equipment for transmitting data via laser between moving airborne or space platforms at rates similar to conventional optical fibre,…
Emerging from investment phase
EQS Group | 11/11/2019
Management reiterated FY19 guidance at the half year, despite revenue growth at the interim stage being a little below its own expectations. H219 should…
FYB201 FDA filing imminent
Formycon | 11/11/2019
Formycon's partner Bioeq IP plans to file FYB201, a Lucentis biosimilar candidate, to treat neovascular age-related macular degeneration (nAMD) with the…
Improving profitability
CLIQ Digital | 11/11/2019
CLIQ Digital’s half year report shows progress quarter-on-quarter, although gross revenues were 8% down on prior year. Margins are starting to improve…
VAR acceleration boosts profitability
Mensch und Maschine Software | 11/11/2019
Mensch und Maschine (M+M) reported 9M19 revenue growth of 30% year-on-year (23% organic) and EBIT growth of 40% (23% organic). The Software business revenue…
Is an H2 catalyst coming?
mVISE | 11/11/2019
mVISE is continuing to make progress on its three-year 2018+ strategy. Recent interims saw headline revenues rise nearly 7% y-o-y and 12% organically.…
Filings in the US and Japan in next six months
Paion | 11/11/2019
Assuming a successful FDA review of remimazolam for procedural sedation (PS), with an outcome due by 5 April 2020, Paion is set for 20–25% royalties…
Eight acquisitions so far this year
Mutares | 11/11/2019
Mutares (MUX) specialises in restructuring distressed companies and has been very active in M&A this year, with eight deals announced to date. It has concluded…
Adding value to the fintech portfolio
FinLab | 11/11/2019
Following the high transaction activity in H218, FinLab has since focused on value creation within its existing fintech portfolio companies. In H119, a…
A play on the German mid-market MBO space
Deutsche Beteiligungs | 11/11/2019
Deutsche Beteiligungs (DBAG) is a well-established private equity company investing primarily in mid-sized German companies. On top of achieving a return…
The land of opportunity awaits NanoTherm
MagForce | 11/11/2019
MagForce is making progress in its strategy to drive the uptake of its thermal ablation treatment, NanoTherm. It is approved in Europe for brain tumours…